NEXT plc (OTCMKTS:NXGPF – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company.
Several brokerages have commented on NXGPF. Santander raised NEXT to an “outperform” rating in a report on Friday, September 25th. Citigroup raised NEXT from a “neutral” rating to a “buy” rating in a research note on Tuesday, August 25th. Morgan Stanley reaffirmed an “overweight” rating on shares of NEXT in a research note on Friday, September 18th. Investec lowered NEXT from a “buy” rating to a “hold” rating in a research report on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of NEXT in a research note on Friday, August 7th.
Read Our Latest Stock Report on NXGPF
NEXT Price Performance
OTCMKTS NXGPF opened at $202.72 on Tuesday. NEXT has a twelve month low of $169.63 and a twelve month high of $210.30. The stock has a 50-day moving average of $199.35 and a 200 day moving average of $191.17.
NEXT Company Profile
NEXT plc is a United Kingdom-based retailer that sells clothing, footwear, accessories, home furnishings and related products. The company operates through a combination of physical stores, websites, mobile applications and catalog-based services, offering merchandise under the NEXT brand and selected third-party and partner brands.
NEXT serves customers primarily in the United Kingdom and also sells internationally through its online platforms and overseas operations. Its business includes retail, online and delivery services, financial services for eligible customers, and brand or product-management services provided to partner businesses.
Founded in 1982, NEXT has developed from a primarily store-based retailer into a digital and multichannel group.
See Also
- Five stocks we like better than NEXT
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for NEXT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXT and related companies with MarketBeat.com's FREE daily email newsletter.
